A
Aurenar
United States · $5.7M raised
- Total Funding
- $5.7M
- Last Round
- $5.7M SeedJul 2026
- Rounds
- 1
About
Non-invasive stroke neuromodulation device
Summary
Aurenar is a Healthcare company based in United States. It has raised $5.7M in total across 1 round, most recently a $5.7M Seed round in Jul 2026.
Funding History
SeedJul 2026
$5.7M
Jul 2026
Similar Companies
Sotera MedicalIPO
operates in the healthcare industry focusing on biotechnology business
Chagrin Falls, United States1–10Healthcare, Medical Devices
Venture Round·$1.1B·Jan 2017
MedlineIPO
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Northfield, United States10001+Healthcare
Private Equity·$34.0B·Jan 2021
MultiPlanIPO
Healthcare cost management company providing data analytics and network-based payment solutions t...
New York, United States1001–5000Healthcare
Private Equity·$7.4B·Mar 2014
The Bountiful CompanyAcquired
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
Ronkonkoma, United States1001–5000Healthcare, Retail
Private Equity·$7.0B·Jul 2017
OneOncologyAcquired
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Nashville, United States1001–5000Healthcare, Data & Analytics
Extension Round·$5.1B·Dec 2025
Tiantan Biological / China Biologic (泰邦生物集团)
China's leading blood products manufacturer
Beijing, China1001–5000Biotech, Healthcare
Growth Equity·$5.1B·Aug 2022